Ani Pharmaceuticals (ANIP) Dividend Coverage Ratio (2021 - 2025)

Ani Pharmaceuticals has disclosed Dividend Coverage Ratio across 5 years of filings, most recently posting 76.38 for Q3 2025.

• In Q3 2025, Dividend Coverage Ratio rose 226.19% year-over-year to 76.38; the TTM figure through Jun 2026 stood at 313.81 (up 4408.08% YoY), while the FY2025 annual figure was 66.71, up 638.04% from the prior year.
• Dividend Coverage Ratio came in at 76.38 for Q3 2025 at Ani Pharmaceuticals, up from 20.0 in the prior quarter.
• In the past five years, Dividend Coverage Ratio ranged from a high of 76.38 in Q3 2025 to a low of 128.03 in Q4 2021.
• Average Dividend Coverage Ratio over 5 years is 7.71, with a median of 2.39 recorded in 2024.
• The largest YoY upside for Dividend Coverage Ratio was 1623.23% in 2024 against a maximum downside of 1526.17% in 2024.
• Over 5 years, Dividend Coverage Ratio stood at 128.03 in 2021, then surged by 91.08% to 11.43 in 2022, then surged by 116.15% to 1.84 in 2023, then sank by 1526.17% to 26.31 in 2024, then jumped by 390.29% to 76.38 in 2025.
• Per Business Quant data, the three most recent Dividend Coverage Ratio figures were 76.38 in Q3 2025, 20.0 in Q2 2025, and 37.62 in Q1 2025.